Persistence of the carteolol hydrochloride/latanoprost fixed-combination ophthalmic solution, compared with the other β-blocker/prostanoid FP receptor agonist fixed-combination ophthalmic solutions.
Kenji KashiwagiKentaro OuchiYoshiyuki ShibasakiMasaki SuginakaPublished in: Japanese journal of ophthalmology (2023)
The study results suggest that persistence rates vary depending on the BB/FP and CAR/LAT appears to be more persistent than other BB/FP.